J. Goldman & Co’s iShares Biotechnology ETF IBB Stock Holding History

J. Goldman & Co’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$389K	Buy	+2,301	New	+$393K	0.01%	537
2025 Q3	–	Sell	-5,600	Closed	-$764K	–	532
2025 Q2	$708K	Buy	+5,600	New	+$687K	0.02%	357
2024 Q3	–	Sell	-10,000	Closed	-$1.37M	–	528
2024 Q2	$1.37M	Buy	+10,000	New	+$1.33M	0.04%	281
2021 Q3	–	Sell	-2,556	Closed	-$418K	–	395
2021 Q2	$418K	Buy	2,556 +363	+17%	+$55.9K	0.02%	333
2021 Q1	$330K	Buy	2,193 +135	+7%	+$21.4K	0.01%	380
2020 Q4	$312K	Buy	+2,058	New	+$294K	0.02%	307
2017 Q4	–	Sell	-4,350	Closed	-$484K	–	384
2017 Q3	$484K	Buy	4,350 +600	+16%	+$64.1K	0.02%	272
2017 Q2	$388K	Buy	+3,750	New	+$369K	0.02%	251
2016 Q2	–	Sell	-1,500	Closed	-$130K	–	369
2016 Q1	$130K	Buy	+1,500	New	+$134K	0.01%	273

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

J. Goldman & Co's IBB Position: Q1 2026 in Review

J. Goldman & Co opened a new position in iShares Biotechnology ETF (IBB) in Q1 2026: 2,301 shares worth $389K. The stake represents 0.01% of the portfolio and ranks #537 among its holdings. This is a return to the name: J. Goldman & Co previously reported a position in IBB as recently as Q2 2025.

J. Goldman & Co first reported a position in IBB in Q1 2016 and has held it in 9 quarters since. The position peaked at $1.37M in Q2 2024. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

J. Goldman & Co held 2,301 shares of iShares Biotechnology ETF worth $389K as of Q1 2026.
iShares Biotechnology ETF was a new J. Goldman & Co position in Q1 2026.
iShares Biotechnology ETF made up 0.01% of J. Goldman & Co's portfolio in Q1 2026, its #537 holding.
J. Goldman & Co first reported a position in iShares Biotechnology ETF in Q1 2016 and has held it in 9 quarters since.
J. Goldman & Co's iShares Biotechnology ETF position peaked at $1.37M in Q2 2024.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.